Brief

"On March 14, 2025, the National Health Surveillance Agency (Anvisa) presented key points and impacts of RDC 954/2024 for the regulated sector. The update aimed to simplify the registration procedure for medicines and address industry demands in a timely manner." "The presentation was conducted in Brasília, with high demand for participation, and made available online for real-time updates."

This content is restricted.

Highlights content goes here...

This content is restricted.

National Health Surveillance Agency (Anvisa)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies